Investment
Features
FeesSafety
Academy
More
Pluang+

TRON's Q1 2026 revenue hits $82.69M, TVL climbs to $5.115B, and it launches exclusive Uquid ticketing platform.

Protocol Fundamentals
15 Apr 2026
Blockonomi
View Source
Bullish
pluang ai news

In Q1 2026, TRON's protocol revenue reached $82.69 million, ranking second among blockchain networks behind Hyperliquid, while its Total Value Locked (TVL) surged to $5.115 billion, indicating strong ecosystem growth. The network became the exclusive blockchain for Uquid's new ticketing platform, enabling digital asset purchases for global live events, tapping into a $900 billion industry. TRON also enhanced security with a Post-Quantum upgrade, positioning itself ahead of Bitcoin and Ethereum in this area. Institutional confidence is shown by Tron Inc.'s recent purchase of 155,886 TRX tokens, increasing treasury reserves beyond 691 million TRX.

More News

Health plan cuts machine-readable file production from 45 days to under 24 hours with TALON integration

Health plan cuts machine-readable file production from 45 days to under 24 hours with TALON integration

A regional nonprofit health plan reduced its Transparency in Coverage machine-readable file (MRF) production time from 45 days to less than 24 hours by integrating TALON's platform directly with its claims administration system. This eliminated a com...

Others
Neutral
1 hour ago
ASUS launches new durable Chromebooks CM15 and CM32 with long battery life and Google AI features in the US

ASUS launches new durable Chromebooks CM15 and CM32 with long battery life and Google AI features in the US

ASUS has introduced two new Chromebooks in the US market: the budget-friendly CM15 laptop and the versatile CM32 Detachable 2-in-1 device. Both run on the MediaTek Kompanio 540 processor, offer up to 12 hours of battery life, and feature military-gra...

Others
Bullish
2 hours ago
Slate Medicines appoints Mark W. Hahn to board to boost migraine drug development.

Slate Medicines appoints Mark W. Hahn to board to boost migraine drug development.

Slate Medicines, a biotech firm focused on migraine treatments, has appointed Mark W. Hahn to its Board of Directors. Hahn brings over 25 years of experience in life sciences, including leading companies through financial milestones and FDA approvals...

Company Fundamentals
Bullish
3 hours ago
Goldman Sachs posts strong Q2 FY2026 with 38% earnings growth and $31B raised in private credit.

Goldman Sachs posts strong Q2 FY2026 with 38% earnings growth and $31B raised in private credit.

Goldman Sachs reported robust Q2 FY2026 results, with net earnings growing at an annualized rate of 38%. The firm raised $31 billion in private credit and saw a 130% year-over-year surge in equity underwriting revenues, driven by major deals and IPO ...

Company Fundamentals
Bullish
4 hours ago
Bitwise Bitcoin ETF offers low fees but struggles with market share and advisor adoption.

Bitwise Bitcoin ETF offers low fees but struggles with market share and advisor adoption.

The Bitwise Bitcoin ETF (BITB) features competitive fees and tight trading spreads comparable to industry leaders like IBIT and FBTC. Despite strong execution on cost and trading efficiency, BITB's market share and asset growth have stalled due to li...

Analyst Insights
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App